xcellon blue logo
Contact
Contact
xcellon blue logo

GMP Manufacturing
Capabilities

Xcellon Biologics is expanding to offer GMP manufacturing capabilities in Maryland. Our upcoming suites will extend the same science-driven approach used in development including our glycoengineering conjugation platform and platform DSP purification into a GMP environment for clinical supply.

Why Programs Choose Xcellon for GMP Readiness

Most tech transfer risks occur when development and GMP processes are misaligned. By building GMP operations around the same technologies used in our development workflows, Xcellon will provide a smoother, lower-risk path into the clinic.

Coming Soon

  • Upstream cell culture capacity up to 1000L scale
  • GMP bioconjugation workflows
  • Integrated bioconjugation DSP purification
  • Clinical-scale supply capabilities

These capabilities will be the natural extension of ADC development services and bioprocess development, supported by analytical and formulation development and monitored with advanced data analytics.

Plan ahead for GMP supply with Xcellon

Plan your GMP supply with confidence. Partner with Xcellon to stay ahead of your development needs. Reach out today to align your program with our upcoming capabilities.
Contact us today

FAQs For ADC Lead Selection

When will GMP manufacturing be available?

Our GMP facility in Maryland will be ready in 2026, stay tuned for updates.

What types of programs will you support?

We will focus on ADC and bioconjugate clinical supply, fully integrated with our development workflows. We will also provide manufacturing services for antibodies, multi-specifics and other complex biologics.

How can sponsors prepare now?

Engaging with us early through ADC Lead Selection, ADC Development, development services and formulation and analytical services, ensures a seamless transition once GMP manufacturing is available.

xcellon white logo
Contact